| Authors: |
Hausdorff WP; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Anderson JD 4th; West Virginia University, Morgantown, West Virginia, USA., Bourgeois AL; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Clifford A; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Fleming JA; PATH, Seattle, Washington, USA., Muhib F; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Pecenka C; PATH, Seattle, Washington, USA., Puett C; Stony Brook University, Stony Brook, New York, USA., Riddle MS; University of Nevada, Reno, Nevada, USA., Scheele S; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Bagamian KH; Bagamian Scientific Consulting LLC, Gainesville, Florida, USA. |
